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Abstract
We examined whether polymorphisms in interleukin-12B (IL12B) associate with susceptibility to pulmonary tuberculosis
(PTB) in two West African populations (from The Gambia and Guinea-Bissau) and in two independent populations from
North and South America. Nine polymorphisms (seven SNPs, one insertion/deletion, one microsatellite) were analyzed in
321 PTB cases and 346 controls from Guinea-Bissau and 280 PTB cases and 286 controls from The Gambia. For replication
we studied 281 case and 179 control African-American samples and 221 cases and 144 controls of European ancestry from
the US and Argentina. First-stage single locus analyses revealed signals of association at IL12B 39 UTR SNP rs3212227
(unadjusted allelic p=0.04; additive genotypic p=0.05, OR=0.78, 95% CI [0.61–0.99]) in Guinea-Bissau and rs11574790
(unadjusted allelic p=0.05; additive genotypic p=0.05, OR=0.76, 95% CI [0.58–1.00]) in The Gambia. Association of
rs3212227 was then replicated in African-Americans (rs3212227 allelic p=0.002; additive genotypic p=0.05, OR=0.78, 95%
CI [0.61–1.00]); most importantly, in the African-American cohort, multiple significant signals of association (seven of the
nine polymorphisms tested) were detected throughout the gene. These data suggest that genetic variation in IL12B,a
highly relevant candidate gene, is a risk factor for PTB in populations of African ancestry, although further studies will be
required to confirm this association and identify the precise mechanism underlying it.
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Introduction
Tuberculosis (TB) contributes significantly to global morbidity and
mortality, with an estimated 2 billion individuals infected worldwide
(http://www.who.int/mediacentre/factsheets/fs104/en/). TB will
likely represent an increasing social and economic burden,
particularly in resource-poor countries, because of newly emerging
multi-drug resistant strains of Mycobacterium tuberculosis (Mtb). Over the
next 20 years the World Health Organization (WHO) estimates that
one billion people will become newly infected and more than 25
millionwilldiefromTB,despitetheavailabilityofantibiotics[1].The
impact of the continuing TB epidemic will likely be greatest in sub-
Saharan Africa, with incidence rates ranging from 50 to greater than
300 per 100 000 individuals [2]. In 2005 there were approximately
3.8 million African TB cases and 550 000 TB-caused deaths with
more than 2.5 million of the cases being new and accounting for 29%
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e16656of the worldwide incidence (http://www.who.int/mediacentre/
factsheets/fs104/en/). In Africa the study of TB is complicated by
the parallel epidemic of HIV because co-morbidity is common,
making it necessary to consider HIV infection, especially in high HIV
prevalence areas.
The vast majorities of those infected with Mtb maintain the
bacterium in a latent state, and fail to develop overt clinical
disease; however, they remain at risk of progressing to disease later
in their lives. The factors determining risk of infection and
progression to active disease are multifactorial, involving host–
pathogen interactions and environmental components [3]. In
addition, innate and adaptive immunity are critical to the
elimination or containment of Mtb, with macrophages playing a
key role [4]. Central to the pathogenesis of TB therefore, is the
inability of infected macrophages to contain Mtb and the failure of
T cells to confer long-lasting protective immunity [2]. In some this
may be due to genetic predispositions, and functional single-
nucleotide polymorphisms (SNPs) in key genes have been
associated with susceptibility and/or resistance to TB [5–7]. In
particular, functional/putatively functional SNPs in genes that
affect macrophage anti-mycobacterial activity (e.g., vitamin D
receptor [VDR], monocyte chemoattractant protein [MCP–1], and
interferon [IFNc]) associate with increased risk for and severity of
tuberculosis in various ethnic groups [6–9].
Compelling evidence indicates that different T cell populations,
including CD4+, CD8+, double-negative, and cd T cells,
participate in protective immunity against TB [10], at least in
part due to their ability to secrete IFNc. A series of Mendelian
immune disorders of the IL12/IFNc axis have been described and
all markedly predispose individuals to severe mycobacterial
diseases [11–15]. Interleukin-12 (IL12) is a heterodimeric cytokine
composed of two subunits, p35 and p40, which are encoded by the
IL12A and IL12B genes, respectively. IL12B gene expression is a
major inducer of IFNc and IL12-p40 is required for IFNc-induced
protection from Mtb. The IL12-p40 subunit also increases
production of IFNc by covalently linking to the p19 subunit of
yet another cytokine, IL23. This linkage can promote IFNc
response in absence of IL12-p35 [13,16]. Additionally, IL12B
expression is significantly decreased in patients with active TB
compared to individuals with latent TB infection, consistent with
the hypothesis that low expression of IFNc in TB patients is due to
the reduction of IL12-p40 [17]. Addition of exogenous IL12
enhanced the IFNc response of ESAT-6-stimulated peripheral
blood mononuclear cells (PBMC) from TB patients, underscoring
the importance of IL12B in the induction of IFNc [17]. Thus the
IL12 role in TB is of increasing interest as rare IL12B gene
mutations cause altered IL12-p40 levels and increased suscepti-
bility to mycobacterial infection (including non-tuberculous
mycobacteria) because of the impaired IFNc mediated immunity
[11,13–15,18].
The purpose of this study was to examine whether polymor-
phisms in the IL12B gene were associated with susceptibility to
pulmonary tuberculosis in two West African populations – from
The Gambia and Guinea-Bissau – and to replicate these findings
in independent samples from North and South America. The
incidence of PTB in Guinea-Bissau is among the highest in the
world (470/100 000). The study area has a population of 92 000
and is composed of several ethnic groups including Papel (32%),
Manjaco (14%), Mancanha (10%), Balanta (9%), Fulani (13%),
Mandinka (7%) and others (15%). The incidence of PTB in the
Gambia is 258/100 000. More than 90% of the population of The
Gambia is from five main ethnic groups, including Mandinka,
Fulani, Wolof, Jola/Karoninka, and Sarahule (a general demo-
graphic description of The Gambia can be found at http://www.
columbia.edu/ ˜msj42/index.htm). In total nine polymorphisms
were examined in 321 PTB cases and 346 controls from Guinea-
Bissau and 280 PTB cases and 286 controls from The Gambia
(however, due to limited availability of DNA, the microsatellite
and the in/del were typed in a slightly reduced number of samples
from The Gambia, see Materials and Methods). Results were then
examined in a mixed case-control replication dataset consisting of
PTB cases, relatives, or close contact controls from 281 cases and
179 controls African-Americans and 221 cases and 144 controls
Caucasians.
Results
Clinical and demographic information for Guinea-Bissau, The
Gambia, and the African-American and Caucasian cohorts has
been previously described [19–21]. Examination of allele and
genotype frequency differences for cases with and without HIV
indicated no evidence for significant differences between the two
groups in any of the populations examined; as a result analyses
were performed pooling cases with and without HIV. A list of the
polymorphisms examined, their base-pair positions, and their
potential role in the gene are provided on Table 1. Differentiation
among ethnic groups (ethnicity was self-identified) within cases and
controls, as measured by Fst were very small in Guinea-Bissau and
The Gambia (less than |0.01| in all cases), indicating little to no
differentiation among ethnic groups within cases and controls for
any of the polymorphisms examined (Table 1). Tests for allele and
genotype frequency differences between Guinea-Bissau and The
Gambia cohorts showed only one significant difference between
the two cohorts: SNP rs3212227 differed in both allele
(p,1.00610
23) and genotype (p=1.00610
26) comparisons in
cases only (Table S1).
Guinea-Bissau
Single locus tests of association identified one significant single
locus effect (Table 2a) in IL12B at SNP rs3212227 for the allelic
test of association (p=0.04). The best genotypic model for IL12B
rs3212227 was additive with an OR=0.78 [95% CI 0.61–0.99]
(p=0.05) (Table 3). When we corrected the genotypic association
for gender, ethnicity and age as covariates neither the p value
changed (0.040 for the additive model vs. 0.044 for the adjusted
model) nor the effect size changed noticeably (0.78 for the additive
model unadjusted vs. 0.77 for the adjusted model) (Table S2).
There were no significant deviations from Hardy Weinberg
Equilibrium (HWE) in cases or controls.
Examination of the linkage disequilibrium (LD) structure of
IL12B in controls (Figure 1a and 1b) revealed strong overall D’ with
D’ ranging between 0.86–0.97 in the 59 block. An evaluation of r
2
indicates that the 59 region (rs6894567 to rs2288831) is separate
from the 39 region of the gene. Of note this overall pattern of LD is
very similar to that in the cases (Figure S1, a and b).
The Gambia
Single locus tests of association in The Gambia identified a
significant allelic association at IL12B SNP rs11574790 (Table 2a)
(p=0.05). The most significant genotype effect for this SNP was
detected for an unadjusted additive model with an OR=0.76
[95% CI 0.58–1.00] (p=0.05). Adjusting for gender, ethnicity and
age only slightly changed the p value to 0.069 and the OR to 0.78
[95% CI 0.58–1.02]. There were no statistically significant
deviations from HWE in cases or controls.
LD of IL12B in The Gambian controls (Figure 1c and 1d),
shows that D’ of rs11574790 with the SNP associated in the
Guinea-Bissau population (rs3212227) is large (0.91, Figure 1c).
IL12B Gene Variation in Pulmonary Tuberculosis
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Gene Marker Position Role Guinea-Bissau The Gambia
Fst
a Fst
a
Cases Controls Cases Controls
IL12B
(5q33.3)
rs3212227 158675528 39 UTR 0.0014 20.0046 0.0004 20.0016
rs11574790 158676424 Intron 6 0.0032 20.0066 20.0051 20.0011
rs2421047 158678885 Intron 5 0.0022 20.0083 20.0045 20.0065
rs919766 158680142 Intron 4 20.0013 20.0043 20.0012 0.0253
rs2288831 158682591 Intron 3 20.0019 20.0063 0.0003 20.0067
rs10631390 158683690 Intron 2 0.0021 0.0013 20.0028 20.0093
rs3212220 158686773 Intron 1 0.0003 0.0018 20.0040 20.0058
rs6894567 158689546 Intron 1 20.0041 20.0058 20.0022 0.0094
rs17860508 158692783 Promoter 0.0010 0.0029 20.0037 0.0064
aFst was calculated as hP within each country and within cases and controls. Unlike Fst, hP can be negative.
doi:10.1371/journal.pone.0016656.t001
Table 2. Single locus allelic and genotypic tests of association in Africans (2a), African-Americans (2b), and Caucasians (2b).
a Gene Marker
Minor
Allele Control MAF Case MAF P-Value
Guinea
Bissau
The
Gambia
Guinea
Bissau
The
Gambia Guinea-Bissau The Gambia
Allele Genotype Allele Genotype
IL12B rs3212227 G 0.31 0.36 0.26 0.40 0.04 0.13 0.19 0.43
rs11574790 A 0.25 0.27 0.24 0.22 0.67 0.88 0.05 0.15
rs2421047 A 0.34 0.34 0.35 0.38 0.76 0.94 0.14 0.24
rs919766 C 0.27 0.29 0.26 0.28 0.90 0.84 0.78 0.95
rs2288831 C 0.39 0.35 0.38 0.38 0.64 0.75 0.29 0.61
rs10631390 B
a 0.36 0.34 0.38 0.37 0.54 0.34 0.36 0.63
rs3212220 A 0.37 0.37 0.37 0.38 0.71 0.58 0.48 0.77
rs6894567 G 0.34 0.31 0.35 0.35 0.84 0.55 0.22 0.42
rs17860508 D
a 0.31 0.29 0.33 0.32 0.45 0.74 0.35 0.68
b Gene Marker
Minor
Allele Control MAF Case MAF P-Value
Guinea
Bissau
The
Gambia
Guinea
Bissau
The
Gambia Guinea-Bissau The Gambia
Allele Genotype
b Allele Genotype
b
IL12B rs3212227 G 0.31 0.36 0.26 0.40 0.04 0.13 0.19 0.43
rs11574790 A 0.25 0.27 0.24 0.22 0.67 0.88 0.05 0.15
rs2421047 A 0.34 0.34 0.35 0.38 0.76 0.94 0.14 0.24
rs919766 C 0.27 0.29 0.26 0.28 0.90 0.84 0.78 0.95
rs2288831 C 0.39 0.35 0.38 0.38 0.64 0.75 0.29 0.61
rs10631390 B
a 0.36 0.34 0.38 0.37 0.54 0.34 0.36 0.63
rs3212220 A 0.37 0.37 0.37 0.38 0.71 0.58 0.48 0.77
rs6894567 G 0.34 0.31 0.35 0.35 0.84 0.55 0.22 0.42
rs17860508 D
a 0.31 0.29 0.33 0.32 0.45 0.74 0.35 0.68
*In bold are statistically significant (p#0.05).
ars10631390 is a microsatellite and was coded so that alleles 131 and 134 were grouped into one category coded B here and the other alleles 125 and 128 were grouped
into another category coded A. rs17860508 is an insertion deletion and the deletion (D) was considered the minor allele.
bGenotype p-values for African-American and Caucasian samples are additive genotype models performed using GEE.
doi:10.1371/journal.pone.0016656.t002
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2 between these two SNPs (Figure 1d), however, was
marginal (r
2=0.16), but slightly stronger than in Guinea-Bissau
(0.13). Again it is important to note that the overall LD structure is
similar in the cases from The Gambia (Figure S1, c and d).
African-Americans and Caucasians
There were no statistically significant deviations from HWE in
African-American or Caucasian cases or controls. Single locus tests
of association in the African-Americans identified seven significant
allelic associations at IL12B polymorphisms rs3212227 (p=0.002),
rs2421047 (p=0.008), rs2288831 (p=0.008), rs10631390
(p=0.001), rs3212220 (p=0.003), rs6894567 (p=0.007), and
rs17860508 (p=0.002) and two significant genotypic associations
at rs3212227 (p=0.05) and rs6894567 (p=0.03) (Table 2b). These
data replicated the association observed in Guinea-Bissau at
rs3212227, with an OR=0.78 (95% CI [0.61–1.00, p=0.047])
(Table S3a). The lack of association in the Caucasian sample may
be due to the unusual reduction in LD in the Caucasian samples
relative to the ones of African ancestry (Figure 1g and 1h).
There appears to be stronger LD and larger LD block structure
forIL12BinAfrican-Americanscontrols(Figure1eand1f)relativeto
controls from Guinea-Bissau (Figure 1a and 1b), The Gambia
(Figure 1c and 1d), and in Caucasians (Figure 1g and 1h), with one
large D’ LD block identified relative to the two blocks identified in
both The Gambia and Guinea-Bissau. This may represent an effect
of admixture causing more extensive LD; this LD structure and the
larger number of single polymorphism associations provide evidence
of association with PTB. As noted above case LD structures are
consistent with controls from the same sample (Figure S1).
Discussion
In this study we observed significant or marginally significant
associations of PTB with IL12B intragenic variants in three
independent populations: The Gambia, Guinea-Bissau and
African-Americans. Although the results in terms of the exact
SNP showing association differed between the two West African
populations, and despite small physical distance between the two
associated polymorphisms (39UTR rs3212227 in Guinea-Bissau
and rs11574790 in intron 6 in The Gambia), this is not unexpected
given the noticeable differences in LD structure and the differences
in haplotype frequencies between Guinea-Bissau and The Gambia
(data not shown). In African-Americans an association was
detected with rs3212227 (thus replicating and reinforcing the
finding in the Bissau cohort), however, in this sample, allelic
association signals were detected throughout the IL12B gene, from
the 39 end to rs17860508, the 7-bp deletion and 3-bp insertion in
the promoter. The association pattern differs in African-Ameri-
cans with respect to West Africans (i.e. broad vs. localized signal)
and this can be explained by the lower levels of LD observed in the
Gambian and Bissau samples (Figure 1), translating into a lower
chance of detecting association over extended genomic distances
in these populations. In addition, it is important that the direction
of association is the same in all three populations, further
reinforcing a conclusion of putative association. However, we
recognize that adding covariates to the genotype model impacted
some, but not all of the associations. For example, the p value did
lose significance for rs11574790 in The Gambian samples, but the
effect size remained very similar and the reduction in significance
is likely due to a reduction in power when additional variables are
added to the statistical model. Therefore, we caution that the
evidence of a common effect across populations of African
ancestry, although reinforcing a possible association, will require
follow-up and replication to confirm them.
One potential caveat with the African-American result lie in the
fact that this population is admixed with Europeans, and that
admixture levels can be variable. Therefore, IL12B allele frequencies
could differ between cases and controls as a reflection of population
stratification. Although we acknowledge that the issue could have
been addressed by typing ancestry-informative markers, these were
not available for this study. In support of lack of population
stratification artefacts is that controls were drawn from the same
residential area of cases and therefore we would expect that
admixture in the two groups is similar. Additionally, the lack of
deviation from HWE and the consistency of LD patterns between
cases and controls indicate that stratificationislimited,ifitexistsatall.
Lastly, the minor allele frequencies across the populations of African
descent for SNPs that show association differ by less than or equal to
only 7% (Table 2), indicating that stratification is not a major factor.
It is likely that the IL12B associations reported here are in fact
due to an unknown variant(s) that is in LD with the polymorphism
positively associated with TB in this study; the discrepancy
between population samples could simply be due to distinct
patterns of genetic variation that is not fully explained by the
Table 3. OR for significant replicated associations from Table 2.
Populations Model (rs3212227) OR 95% CI P-Value
Guinea-Bissau Additive (TT (major allele homozygote), GT, GG (minor allele homozygote)) 0.78 0.61–0.99 0.05
TT&GT v GG (Baseline) 1.65 0.91–3.05 0.08
GG&GT v TT (Baseline) 0.77 0.56–1.07 0.11
The Gambia Additive (TT (major allele homozygote), GT, GG (minor allele homozygote)) 1.18 0.91–1.55 0.21
TT&GT v GG (Baseline) 0.8 0.45–1.39 0.39
GG&GT v TT (Baseline) 1.24 0.84–1.84 0.25
African-American Additive (TT (major allele homozygote), GT, GG (minor allele homozygote)) 0.78 0.61–1.00 0.05
TT&GT v GG (Baseline) 1.21 0.72–2.03 0.48
GG&GT v TT (Baseline) 0.69 0.49–0.98 0.04
Caucasian Additive (TT (major allele homozygote), GT, GG (minor allele homozygote)) 0.89 0.58–1.37 0.59
TT&GT v GG (Baseline) 0.96 0.22–4.20 0.95
GG&GT v TT (Baseline) 0.85 0.51–1.42 0.53
*In bold are statistically significant (p#0.05).
doi:10.1371/journal.pone.0016656.t003
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there are strikingly different genetic backgrounds across the
African continent, especially compared to non-African popula-
tions, despite substantial shared ancestry [22]. This is further
supported by the differences between both the Guinea-Bissau and
The Gambia samples as compared to the data from the Yoruba
samples from the HapMap project.
Yoruba
IL12B haplotype frequencies (parental haplotypes only) showed
significant differences in haplotype frequencies compared to
controls from Guinea-Bissau and The Gambia. There was also
stronger overall LD in the Yoruba (Figure S2, b and d). We also
observed stronger associations in IL12B in African-Americans with
similar effect sizes to Guinea-Bissau, indicating that we are
perhaps seeing more associations in African-Americans due to
stronger overall LD, possibly due to the relatively recent
admixture that formed this population. These comparisons
confirm that ‘‘neighboring’’ African populations might display
considerable variability in LD, and suggests that functional
variants at the 39 end of IL12B may be differentially tagged in
these West African populations. Hence, association of nearby
polymorphisms (e.g., rs3212227 and rs11574790) can be reason-
ably interpreted as strong evidence for association with IL12B.
Proof of this will require additional fine mapping in order to better
understand the role of IL12B in PTB. Unfortunately, haplotype
analyses did not refine a smaller region of association as compared
to that detected by single SNPs nor did haplotype analyses
improve significance levels (data not shown); rather haplotypes
turned out to be uninformative due to the larger number of
haplotypic variants generated by the polymorphisms (including a
microsatellite) typed across the gene.
Our findings are interesting because of the consistency we were
able to demonstrate in these distinct populations, yet there are
some potential limitations to be considered. First, TB disease was
defined somewhat differently in the original populations from The
Gambia and Guinea-Bissau, compared with disease definition in
the replication dataset since none of the former samples were
culture-confirmed, while all of the latter were culture-confirmed.
This potential heterogeneity in case definition is less concerning
because, if anything, it is more likely to reduce the chances of
finding real differences between cases and controls. Similarly,
controls were selected from households in Guinea-Bissau where
there was no evidence of recent TB exposure, whereas the other
sites included and even sought controls that had been exposed to
the index case. In addition, we had HIV data on 70% of the
American samples, 90% of the Guinea-Bissau samples and 87% of
The Gambia. We included the small number of known HIV-
positive cases in our analyses, which could result in confounding
by ascertainment center or HIV status. To account for these
effects we adjusted for ascertainment site in our models and
conducted a sensitivity analysis of HIV status by removing HIV-
positive cases from our analysis. However, HIV status did not
influence the significance of our results and was therefore not
reported explicitly.
We observed some baseline differences for the ratio of males to
females and mean age at examination in cases and controls. We
adjusted for these effects in our models, but these variables do not
affect our point estimates of the effect size substantially, with
changes in OR much less than 0.10, indicating that these variables
are not confounders. We did not correct for multiple testing in our
analyses, but our study design was to replicate any association signal
detected in West Africans in subsequent cohorts, i.e., the African-
American and the Caucasian, an approach that had the advantage
of minimizing false positive results. The fact that SNP rs3212227
was replicated and had a small allelic p value in the African-
Americans (p=0.002) suggests that this design did in fact enable us
to identify a real association, worthy of follow-up in future studies.
The results of this study implicate IL12B as a susceptibility gene
forPTBinWestAfricansfrom TheGambiaand Guinea-Bissauand
in African-Americans. Although negative associations between
IL12B and PTB have been reported in small (underpowered)
population-based studies [23,24], our results, indicating a role for
IL12B variation in TB susceptibility, are in agreement with studies
in Hong Kong Chinese [25], Russian [16], Indian [26] and
Indonesian population samples [27].Inadditiona recentstudyfrom
South Africa, that analyzed an admixed cohort from Cape Town,
showedweakevidenceforassociation withIL2Bvariation,including
some of the polymorphisms we examined [28]. Taken together, our
multi-ethnic replication study suggests that IL12B sequence
variation influences risk for pulmonary PTB either directly or
through LD with a functional variant. Of all the polymorphisms we
tested, only rs17860508 (insertion/deletion) and SNP rs3212227
(corresponding to a TaqI restriction site) have been shown or
suggested to have functional effects: rs17860508 on IL12B mRNA
levels [29] and rs3212227 on IL12p70 secretion [30]. The fact that
not all studies find a clear association, does not by itself invalidate
the several positive findings. It has been shown that in an epistatic 2
locus model, the effects ofa single gene may be impacted by variants
elsewhere in the genome and that when variants at a second
unmeasured locus differ in allele frequencies among populations
power to detect association at the first locus can be changed
substantially among them [31]. It is noteworthy that rs3212227,
which was replicated in the African-American cohort lies in an
evolutionarily conserved region (analyses not shown; Vista Browser
2.0, http://genome.lbl.gov/vista/index.shtml), reinforcing the idea
that the 39 end of gene might play a significant functional role in vivo
[32]. Elucidation of the role of IL12B in susceptibility to PTB
requires isolating the functional variants in IL12B most affecting the
pathogenesis of disease. In addition, isolation of IL12B variants
related to pathogenesis of PTB could result in the identification of
susceptible individuals as well as in a better understanding of factors
modulating vaccine-dependant responses for which IL12 promotes
and sustains Th1 immunological memory [33].
Materials and Methods
Study Populations
Guinea-Bissau. This case-control study was conducted at the
Bandim Health Project (BHP), a demographic surveillance site in
Bissau, the capital of Guinea-Bissau. BHP has followed this
Figure 1. Haploview IL12B linkage disequilibrium plots for controls. All figures are oriented 59 to 39, right to left, relative to the gene
orientation on the minus strand. Linkage disequilibrium (LD) plots characterizing haplotype blocks in IL12B in Guinea-Bissau (Figure 1a and 1b), The
Gambia (Figure 1c and 1d), African-Americans (Figure 1e and 1f), and Caucasians (Figure 1g and 1h). In the first column are LD plots for pairwise D’
between markers and in the second column are LD plots for pairwise r
2 between markers. Both r
2 and D’ values are indicated in percentages within
squares in the LD plot. Strong LD is indicated by dark gray/red, while light gray/pink and white indicate uninformative and low confidence values,
respectively. LD Blocks were created with the default algorithm in HaploView program (version 4.1) that creates 95% confidence bounds on D’
considered being in strong LD where 95% of the comparisons made are informative.
doi:10.1371/journal.pone.0016656.g001
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Guinea-Bissau sample have been previously reported [19].
Patients included in the study (cases) were residents or long-term
guests of Bissau, aged .15 years, newly PTB-diagnosed using
three sputum examinations for acid fast bacteria or clinical criteria
by the World Health Organization’s definition of active
pulmonary PTB [34]. No culture confirmation of TB was
available in Bissau, during the study period, as facilities were
destroyed during a civil war; 218/321 (68%) were smear positive.
Patients with newly diagnosed TB were enrolled when they started
antitubercular treatment at local health centers. During the
inclusion period from November 2003 to November 2005, 438
TB patients were screened at local health centers: 344 subjects met
inclusion criteria and accepted participation, and from these we
could obtain 321 DNA samples. There were no exclusion criteria.
Healthy controls were recruited from the study area from May
2005 to November 2005. A random sample of 200 houses was
selected from the database of all subjects living in the study area,
and houses with a recorded case of TB within the past 2 years were
excluded from the sampling. Exclusion criteria for controls
included the presence of cough for more than 2 weeks, history
of TB and TB in the household within the last 2 years to avoid
households with a high-risk of active TB. The composition of the
case and control samples was different in terms of sex and
ethnicity. These differences are due to the sampling strategy as
controls were derived from healthy nuclear families; hence more
healthy married couples were collected, whereas TB patients are
more often males. The ethnic differences are due to willingness of
healthy subjects to give blood, which was not the same across the
ethnic groups, whereas most TB patients agreed to participate in
the study regardless of their ethnic background.
All subjects were interviewed by field assistants, using a
standardized questionnaire on ethnicity, environmental factors
and prior exposure to TB. Permission to perform HIV tests was
asked for cases but not for controls, as requiring HIV testing would
have negatively impacted participation in the study. Venous blood
samples (4 ml in ethylenediaminetetraacetic acid) were collected
from all subjects. Ethical approval was granted by the ‘Unidade de
Coordenacao de Estudos e Pesquisas em material de Saude’
(Ministry of Health) in Guinea-Bissau. All adults and children’s
guardians signed an informed consent to the study.
The Gambia. Between June 2002 and October 2004, PTB
cases and their household contacts were enrolled in a prospective
cohort study in the Greater Banjul region of The Gambia, where
about 750 000 people live, i.e. more than 50% of the total
Gambian population (http://www.columbia.edu/,msj42/index.
htm). Our Gambian cohort consisted of Mandinka (34%), Jola
(29%), Wolof (13%), Fulani (9%), Serere (6%), Manjaco (3.5%),
Sarahule (1%), Aku (1.%) and others (3.5%). According to WHO
2007 burden estimates, the incidence of TB in The Gambia is
258/100 000 and 11% of new TB cases are HIV positive (http://
www.who.int/globalatlas/predefinedReports/TB/PDF_Files/gmb.
pdf). Recruitment took place from the major government TB clinic
and the Medical Research Council (MRC) outpatients’ clinic, and
consisted of sputum smear positive pulmonary TB cases aged at least
15 years old, who had at least one household contact living with
them [20]. Included patients (screened for HIV) had two sputum
smear samples positive for acid-fast bacilli and with M. tuberculosis
isolated upon culture. An index case was defined as the first TB case
identified in a household. Household contact controls were defined
as individuals at least 6 months of age living the majority of the time
on the same compound as the respective index TB case, sharing
meals and identifying a common household head. Written informed
consent was obtained from all subjects. The study was approved by
the combined Gambia Government/MRC National Ethics
Committee of The Gambia.
As with Guinea-Bissau subjects were interviewed by field
assistants, using a standardized questionnaire on ethnicity,
environmental factors and prior exposure to TB. Permission to
perform HIV tests was asked for cases but not for controls. Venous
blood samples (4 ml in ethylenediaminetetraacetic acid) were
collected from all subjects, and from these, 286 control DNA
samples and 280 case DNA samples were genotyped for analyses.
All samples were archived in the National Gambian DNA Bank
and used in compliance with the bank guideline [35].
African-Americans and Caucasians. Participants were
ascertained through the North Carolina or South Carolina TB
Control Programs, U.S.A., or as patients at the outpatient clinic at
F.J. Mun ˜iz Hospital in Buenos Aires, Argentina, between 2002
and 2006. Criteria for inclusion as TB cases were: a) age 14 years
or older and culture-confirmed pulmonary TB, or b) younger than
14 years old and either culture-confirmed or clinically diagnosed
pulmonary TB that included a positive tuberculin skin test plus an
infiltrate or hilar adenopathy on chest x-ray. Individuals were
eligible to participate if TB had been diagnosed in the past, or if
they were currently receiving TB treatment. Family members of
eligible TB cases, who themselves had a history of TB, were
enrolled as part of a multi-case family if review of their records
established diagnosis of pulmonary TB. Details on the study
population are provided by Velez et al. [21].
Severity of TB disease was assessed by presence of acid-fast bacilli
(AFB) in sputum smears or x-ray evidence of cavitary lesions. We
attempted to document HIV status through medical record review
for all subjects. However, participation in this study did not require
that the individual authorize review of HIV test results.
Unaffected individuals who were in close contact with cases
(household contacts such as spouses and partners, and relatives
such as parents and siblings) were enrolled as controls.
Informed consent was obtained from all subjects or their legal
representatives before participation in the study. Human exper-
imentation guidelines of the U.S. Department of Health and
Human Services and those of the participating research institu-
tions were followed. The protocol was IRB-approved at Duke
University Medical Center, the North and South Carolina
Departments of Public Health (USA), Centro de Educacio ´n
Me ´dica e Investigaciones Clı ´nicas ‘‘Norberto Quirno’’ (CEMIC),
the F.J. Mun ˜iz Hospital, Buenos Aires, Argentina, and the
University of Miami Miller School of Medicine.
DNA extraction and genotyping
All DNA samples were extracted using a standard salting-out
procedure (Guinea-Bissau and The Gambia) or the Puregene
method from Gentra systems (African-Americans and Caucasians).
DNA purities were estimated spectrophotometrically, and final
concentrations were determined by PicoGreen. For Guinea-Bissau
and The Gambia samples (4 ng of DNA) were genotyped by
TaqMan assays (ABI, Applera International Inc, Foster City, CA,
USA) in 10 ml reaction volume, using the Rotor-Gene 3000
(Corbett Robotics Pty Ltd, Brisbane, Queensland, Australia) and
the ABI 7500 real-time PCR systems. Fluorescence curves were
analyzed with the Rotor-Gene Software version 6 and the 7500
Sequence Detection Software version 1.2.1 for allelic discrimina-
tion. Replication genotyping in African-American and Caucasian
samples also used TaqMan assays on an ABI 7900 instrument
(ABI, Applera International Inc, Foster City, CA, USA). All
samples were analyzed for seven SNPs, one in/del and one
microsatellite that were selected based on physical location, minor
allele frequency 0.20 in the Yoruba population of the HapMap
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previously reported association. Of these nine variants one SNP in
IL12B was in a 39UTR region (rs3212227); one polymorphism was
in the IL12B promoter region (in/del rs17860508; typed according
to [25]); the remaining SNPs were in intronic regions; one
polymorphism was a microsatellite (rs10631390, previously known
as marker D5S2941) in intron 2 [36,37], typed according to the
method described by [37] with a slight modification in primers
design: 59FAM-TCACCAGTGGAGATTTTCATTC39 (for-
ward) and 59 TTGGCCTCAGTACGCTTCTT 39 (reverse) were
used for genotyping (Table 1). The genotyping of West African
samples was completed in two separate experiments. For the first
experiment seven markers were genotyped in 321 PTB cases and
346 controls from Guinea-Bissau and in 280 PTB cases and 286
controls from The Gambia. In the second experiment two markers
(rs10631390 and rs17860508) were typed in the 321 PTB cases
and 346 controls from Guinea Bissau and in 231 PTB cases and
251 controls in The Gambia. Therefore, due to a limited
availability of DNA, only 482 Gambian samples were genotyped
in the second experiment, all of which however overlapped with
the set of 566 analyzed in the first experiment.
Bioinformatics Tools
SNP positions (base pair [bp]) and function were identified using
the SNPper (http://snpper.chip.org) database NCBI Build 35.1
(Table 1). The HapMap database (http://www.hapmap.org) was
used to obtain linkage disequilibrium (LD) and genotype
information from the Yoruba and CEPH populations.
Statistical Methods
Quality control. All analyses were performed separately for
the four cohorts (Guinea Bissau, The Gambia, African-Americans,
and Caucasians). Because the samples from Guinea Bissau and The
Gambia were known to contain individuals from different ethnic
groups we wanted to test if the polymorphisms we assayed showed
evidence of differences among groups. We used Wright’s inbreeding
coefficient Fst to assess this, the Fst statistic tests for reduction in
heterozygosity due to population subdivision [38]. The rule of
thumb proposed by Wright is that values of Fst less than 0.05
indicate little orno differentiation among populations [39]. We used
Tools for Population Genetics Analysis statistical software, version
1.3 (available at http://www.marksgeneticsoftware.net/) to
measure Fst [40]. For Guinea Bissau and The Gambia we also
performed direct comparisons of allele and genotype frequencies for
both cases and controls as well as for common ethnic groups
between the two populations, tests for deviations from Hardy
Weinberg Equilibrium (HWE), and tests for single locus allele and
genotype frequency differences using Powermarker statistical
software [41,42]. Tests for deviations from HWE in African-
Americans and Caucasians were calculated using genetic data
analysis (GDA) software [43]. Statistical significance for these
analyses was determined using Fisher’s exact test.
Pairwise LD was characterized and haplotype frequencies were
calculated using HaploView [44] statistical software. Standard
summary statistics D’ and r
2 were calculated using HaploView
[45]. D’ is a normalized measure of association among SNPs in a
population [46] and r
2 is the correlation of SNPs in a population
that takes into account differences in allele frequencies and is less
sensitive to inflation due to small sample size; both are measures of
the patterns of allelic association within a population sample, with
values 0 and 1 corresponding to no and maximum possible LD,
respectively. Haplotype blocks were assigned, using the D’
confidence interval algorithm created by Gabriel et al. [47].
Single polymorphism association. Single locus tests of
allelic and genotypic association in Guinea-Bissau and The
Gambia were performed using a Fisher’s exact test available in
Powermarker software and followed-up with logistic regression for
measures of odds ratios (OR) and confidence intervals (CI).
Logistic regression was used modeling additive (0 (homozygous
major allele) vs. 1 (heterozygous) vs. 2 (homozygous minor allele)),
dominant (0 (homozygous major allele) vs. 1 (heterozygous and
homozygous minor allele)), and recessive (0 (homozygous major
allele) vs. 1 (homozygous minor allele)) genotypic models. All
logistic regression models were further examined with adjustments
for potential confounders, ethnicity and gender, for potential
inclusion in the regression model presented in the manuscript.
Criteria of a change in effect size greater than or equal to 0.10 was
determined to indicate evidence for statistical confounding.
Neither gender nor ethnicity showed significant evidence for
confounding effects and are therefore not included in the
regression models presented in the main text. Nonetheless,
analyses were still run adjusting for these parameters because
stratification may play a role in association (see Table S2). Logistic
regression analyses were performed using STATA 9.0 statistical
software, College Station, TX.
For African-Americans and Caucasians single locus genotypic
tests of association (additive model) were performed with
generalized estimating equations (GEE) using the independence
correlation matrix implemented in SAS (PROC GENMOD)
statistical software version 9.1 (SAS Institute, Cary, NC). GEE
performs case-control comparisons in family data by accounting
for correlations among related individuals such as concordant
and discordant siblings, relative pairs, as well as including
unrelated close contacts. GEE performs a valid test of gene x
gene and gene x environment interactions in mixed family and
case-control data [48]. We also performed GEE analyses
adjusting for the potential confounders, age and gender for all
analyses. The point estimates did not significantly change
(change in OR ,0.10), although p values did, when including
age and gender for all analyses (see Table S3), supporting the
conclusion that for these analyses age and gender are not
confounders. Family-based tests of allelic association were
performed with Association in the Presence of Linkage (APL)
test [49]. APL provides a test of association in the presence of
linkage that also estimates missing parental genotypes in nuclear
families by using identity by descent (IBD) parameters and
pedigree information. However, APL does not permit adjust-
ment for covariates so allelic analyses do not include these
adjustments. For Caucasians we also incorporated ascertain-
ment site in all models in order to account for potential genetic
heterogeneity between ascertainment sites. GEE and APL were
used for analyses in African-Americans and Caucasians due to
the different data structures of the populations being examined
(e.g. African-Americans and Caucasians consist of related
individuals while the West African populations are unrelated
cases and controls).
Supplementary information is available at PLoS ONE’s website.
Supporting Information
Figure S1 LD plots for IL12B variants in cases. Linkage
disequilibrium (LD) plots characterizing haplotype blocks in IL12B
in Guinea-Bissau (a, b), The Gambia (c, d), African-Americans (e,
f), and Caucasians (g, h). In the first column are LD plots for
pairwise D’ between markers and in the second column are LD
plots for pairwise r
2 between markers. Refer to Figure 1 legend for
a description of the color scheme used to define pairwise LD
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HaploView program, version 4.1.
(PPT)
Figure S2 LD plots for IL12B variants genotyped in
European (CEPH) and African (Yoruba) HapMap sam-
ples. Linkage disequilibrium (LD) plots characterizing haplotype
blocks in IL12B in the CEPH and Yoruba populations of the
HapMap. In the first column are LD plots for CEPH populations (a
is the D’ and c is the r
2 LD plot) and in the second column are LD
plots for the Yoruba population (b is the D’ and d is the r
2 LD plot).
Please refer to Figure 1 legend for a description of the color scheme
used to define pairwise LD between polymorphisms. The haplotype
blocks were created using HaploView program, version 4.1.
(PPT)
Table S1 Allele and genotype frequency differences between
The Gambia and Guinea Bissau.
(DOC)
Table S2 OR for significant replicated associations from Table 2
adjusted for ethnicity, age and gender.
(DOC)
Table S3 OR for African Americans unadjusted (a), OR for
African Americans adjusted for age and gender (b).
(DOC)
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